| 2025年年报 | 2024年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 非输液(元) | 8,347,953,907.46 | 8,082,551,331.51 |
| 输液(元) | 2,533,300,255.47 | 3,036,307,548.94 |
| 营业成本(元) | ||
| 非输液(元) | 3,339,722,406.16 | 3,363,015,694.63 |
| 输液(元) | 1,233,118,194.43 | 1,391,458,536.69 |
| 毛利(元) | ||
| 非输液(元) | 5,008,231,501.30 | 4,719,535,636.88 |
| 输液(元) | 1,300,182,061.04 | 1,644,849,012.25 |
| 毛利率(%) | ||
| 非输液(%) | 59.99 | 58.39 |
| 输液(%) | 51.32 | 54.17 |
| 收入构成(%) | ||
| 非输液(%) | 76.72 | 72.69 |
| 输液(%) | 23.28 | 27.31 |
| 毛利构成(%) | ||
| 非输液(%) | 79.39 | 74.16 |
| 输液(%) | 20.61 | 25.84 |